NASDAQ : NPCE
-$0.29 (-1.84%)
0.00%
4
change: -110 | last: 1144
change: -63 | last: 670
change: -36 | last: 362
change: -26 | last: 28111
change: 96 | last: 15-
-
0.00
change: 0 | last: 01401
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | OrbiMed Advisors LLC | 2.1M | 6.20% |
| 2026-05-15 | First Light Asset Management, LLC | 2.87M | 8.40% |
| 2025-11-07 | Soleus Private Equity Fund I, L.P. | 310.32K | 0.90% |
| 2025-09-03 | KCK LTD. | - | 0.00% |
| 2025-08-14 | OrbiMed Advisors LLC | 2.61M | 8.00% |
| 2025-08-05 | Soleus Private Equity Fund I, L.P. | 310.32K | 0.90% |
| 2025-05-15 | OrbiMed Advisors LLC | 3.41M | 10.50% |
| 2025-05-15 | Polar Capital Holdings Plc | 2.97M | 9.13% |
| 2025-02-14 | Kent Lake PR LLC | 1.48M | 4.90% |
| 2025-02-11 | KCK LTD. | 5.27M | 17.70% |
| 2025-02-04 | Morgan Stanley | 2.49M | 8.30% |
| 2023-02-10 | Morgan Stanley | 2.19M | 8.80% |
| 2023-02-10 | Morgan Stanley Capital Services LLC | 2.19M | 8.80% |
| 2023-02-09 | Abigail P. Johnson | 1.45M | 5.82% |
| 2023-02-09 | FMR LLC | 1.45M | 5.82% |
| 2022-11-21 | Uri Geiger | 4.04M | 16.20% |
| 2022-11-21 | Accelmed Partners II LP | 4.04M | 16.20% |
| 2022-11-21 | Accelmed Partners II, LLC | 4.04M | 16.20% |
| 2022-11-21 | Accelmed Partners II GP, L.P. | 4.04M | 16.20% |
| 2022-10-07 | KCK Ltd. | 5.62M | 4.00% |
| 2022-01-13 | Covidien Group S.a.r.l. | 965.94K | 3.97% |
| 2022-01-13 | Medtronic plc | 965.94K | 3.97% |
| 2021-11-01 | Equity GP I, LLC | 592.19K | 2.40% |
| 2021-11-01 | Equity Fund I, L.P. | 592.19K | 2.40% |
| 2021-11-01 | LLC | 1.24M | 5.10% |
| 2021-11-01 | Group, LLC | 1.24M | 5.10% |
| 2021-11-01 | Levy | 1.84M | 7.60% |
| 2021-11-01 | LLC | 592.19K | 2.40% |
| 2021-11-01 | Master Fund, L.P. | 1.24M | 5.10% |
| 2021-05-03 | Medtronic plc | 1.27M | 5.30% |
| 2021-05-03 | Covidien Group S.a.r.l. | 1.27M | 5.30% |
| 2021-04-29 | OrbiMed Advisors LLC | 4.01M | 16.80% |
| 2021-04-29 | OrbiMed Capital GP VI LLC | 4.01M | 16.80% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $15.44 | 32.72M | $505.23M | $21.69M | $70.84M | $554.38M |
| 2024-12-31 | $11.19 | 29.13M | $325.92M | $13.43M | $73.34M | $385.83M |
| 2023-12-31 | $10.31 | 25.85M | $266.53M | $18.06M | $72.4M | $320.87M |
| 2022-12-31 | $1.49 | 24.59M | $36.65M | $6.6M | $69.77M | $99.81M |
| 2021-12-31 | $10.08 | 16.61M | $167.42M | $19.19M | $49.85M | $198.08M |
| 2020-12-31 | $24.96 | 11.1M | $277.14M | $26.39M | $52.86M | $303.61M |
| 2019-12-31 | $24.96 | 11.1M | $277.14M | $4.12M | $62.8M | $335.82M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13.15 | 33.72M | $443.38M | $14.78M | $70.46M | $499.06M |
| 2025-12-31 | $15.44 | 32.72M | $505.23M | $21.69M | $70.84M | $554.38M |
| 2025-09-30 | $10.31 | 33.13M | $341.62M | $20.65M | $71.18M | $392.15M |
| 2025-06-30 | $11.14 | 32.86M | $366.09M | $22.86M | $71.52M | $414.76M |
| 2025-03-31 | $12.29 | 31.48M | $386.9M | $27.02M | $73.15M | $433.03M |
| 2024-12-31 | $11.19 | 29.91M | $334.75M | $13.43M | $73.34M | $394.65M |
| 2024-09-30 | $6.97 | 29.44M | $205.23M | $15.42M | $73.5M | $263.31M |
| 2024-06-30 | $7.32 | 28.85M | $211.21M | $12.84M | $73.66M | $272.02M |
| 2024-03-31 | $13.68 | 28.29M | $386.94M | $13M | $73.08M | $447.03M |
| 2023-12-31 | $10.31 | 25.93M | $267.39M | $18.06M | $72.4M | $321.72M |
| 2023-09-30 | $9.73 | 26.02M | $253.15M | $9.72M | $71.69M | $315.13M |
| 2023-06-30 | $4.49 | 25.47M | $114.37M | $7.86M | $71.02M | $177.53M |